Investor Presentaiton

meQuilibrium-Company Overview COMPANY OVERVIEW meQuilibrium Market Segment: Headquarters: CEO: Human Capital Management Boston, MA Jan Bruce • SaaS-based proprietary resilience development solutions powered by predictive analytics and Al for organizations to manage their human capital and develop engaged, agile workforces • The Company offers solutions for individual employees (Engage), managers and teams (Empower), and HR and Benefits managers (Gateway and Collaborate). Solutions are multi-modal and global • The solution increases engagement, productivity, and performance and improved outcomes in retaining and developing top talent and managing stress, health, and well-being ⚫ Its product suite is sold as a per-employee-per-year SaaS delivered in a desktop or mobile environment THESIS • Human Capital Management ("HCM") software market was estimated at $14.5B in 2017, and is expected to grow to $22.5B by 20231 ⚫ Current customer base of over 40 Fortune 500 clients and in 60+ countries • Contracts are 2-3 years with each year typically paid upfront by customers • Demonstrable ROI within key early adopters, including Comcast, HP, and JPMorgan Emphasis on HCM (versus wellness) opens up new potential customers and strategic channel partners, maximizing topline growth potential Opportunity to maximize products being sold to a single customer (land and expand) Origin: Capital: Ownership: Financing Rounds: Other Investors: Board Member: SUMMARY April 2015 $14.0M 32% Primary / 23% Fully Diluted Series B, Series C, Series C extension HLM Venture Partners, Chrysalis Ventures Gary Kurtzman REVENUE MODEL meQuilibrium's product is sold as a PEPY software-as-a-service delivered in a desktop or mobile environment. Most current contracts are 2-3 years in length and each year is typically paid upfront by customers. COMPETITORS Castlight Health (CSLT), Limeade, Happify, Headspace, Optum, Success Factors (SAP), Whil, others G www.safeguard.com © 2021 Safeguard Scientifics, Inc. All rights reserved. SFE LISTED NYSE 1. Based on industry and market reports 20

View entire presentation